This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castro, A. R.
Right arrow Articles by Pope, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castro, A. R.
Right arrow Articles by Pope, V.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, March 2000, p. 197-199, Vol. 7, No. 2
1071-412X/00/$04.00+0

Lipid Removal from Human Serum Samples

Arnold R. Castro,* William E. Morrill, and Victoria Pope

Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333

Received 13 August 1999/Returned for modification 4 November 1999/Accepted 29 December 1999

The efficacy of lipid removal from human serum samples obtained by using Cleanascite HC, a commercially available product, was compared to that obtained by the standard chloroform method. Separate samples of 21 frozen, banked human serum samples used in the preparation of samples for proficiency testing were treated with either Cleanascite HC or chloroform. The lipid content was measured before and after treatment. The total percentages of lipid removed ranged from 61 to 70% with Cleanascite HC and from 60 to 62% with chloroform. The advantage of Cleanascite HC over chloroform is based on the simplicity of the procedure with Cleanascite HC without the environmental concerns inherent in the use of chloroform. In 15 serum samples known to contain antibodies to treponemal and nontreponemal syphilis antigens, Cleanascite HC bound some immunoglobulin, but with only minimal loss of reactivity in the serologic tests for syphilis. Cleanascite HC is therefore an acceptable alternative to chloroform for lipid reduction in human serum samples.


* Corresponding author. Mailing address: Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, 1600 Clifton Rd., Mail Stop D-13, Atlanta, GA 30333. Phone: (404) 639-2874. Fax: (404) 639-3976. E-mail: ajc5{at}cdc.gov.


Clinical and Diagnostic Laboratory Immunology, March 2000, p. 197-199, Vol. 7, No. 2
1071-412X/00/$04.00+0